Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05364008 · ClinicalTrials.gov registry record · Phase 3
FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea
A Phase 3 study of Leiomyoma, Uterine, sponsored by Yale University.
- Active
- Registry status
- Phase 3
- Development phase
- 33
- Enrollment target
- 4
- Study locations
NCT05364008 is a Phase 3 study of Leiomyoma, Uterine that is active but no longer recruiting, run by Yale University. The registered enrollment target is 33 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT05364008, a Phase 3 study of Leiomyoma, Uterine, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 33 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of this study is to determine the effect of low caffeine green tea extract containing 45% epigallocatechin gallate (EGCG) on fibroids and subsequent pregnancy and live births in women seeking fertility treatment. The population will consist of 50 women desirous of conceiving, ages ≥18 to ≤40 years (at time of consent), and known to have class 2-6 fibroids, according to the FIGO staging system.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Green Tea Extract
Study Locations (4)
Illinois
- University of Illinois at Chicago College of Medicine - Chicago
- University of Chicago, Department of Obstetrics and Gynecology - Chicago
Connecticut
- Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences - New Haven
Maryland
- Johns Hopkins, Division of Reproductive Science and Women's Health Research - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2023-01-05 |
| Est. Completion | 2026-09-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05364008
The ClinicalTrials.gov registry entry for NCT05364008 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Leiomyoma, Uterine appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05364008 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Illinois, Connecticut, Maryland.
Frequently Asked Questions
What is clinical trial NCT05364008 about?
NCT05364008 is a clinical study titled "FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea". The objective of this study is to determine the effect of low caffeine green tea extract containing 45% epigallocatechin gallate (EGCG) on fibroids and subsequent pregnancy and live births in women seeking fertility treatment. The population will consist of 50 women desirous of conceiving, ages ≥18...
What is the current status of trial NCT05364008?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 33 participants. The study started on 2023-01-05. Estimated completion is 2026-09-30.
What conditions does trial NCT05364008 study?
This clinical trial studies the following conditions: Leiomyoma, Uterine.
What interventions are being tested in trial NCT05364008?
The interventions under investigation include: Placebo (OTHER), Green Tea Extract (DRUG).
Who is sponsoring clinical trial NCT05364008?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05364008 being conducted?
This trial has 4 study locations across Connecticut, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leiomyoma, Uterine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.